[NEJM] Survival with Osimertinib plus Chemotherapy inEGFR-Mutated Advanced NSCLC

GEOMAN23 Post time The day before yesterday 15:17 | Show all posts |Read mode
This post will be closed automatically in 2026-08-01 15:17
Reward10points

journalㄩNew England Journal of Medicine

AuthorsㄩPasi A. Jnne; David Planchard; Kunihiko Kobayashi; James Chih-Hsin Yang; Ying Liu; Natalia Valdiviezo; Tae Min Kim; Liyan Jiang; Hiroshi Kagamu; Noriko Yanagitani; Jialei Wang; Bivas Biswas; Artem Poltoratskiy; Yeni Neron; Carlos Rojas; Leona Koubkova; Carles Escriu; Doreen A. Ezeife; Helen Mann; Elena Armenteros-Monterroso; Yuri Rukazenkov; Chee Khoon Lee

Published dateㄩ2026-1-1

DOIㄩ10.1056/nejmoa2510308

PDF linkㄩhttp://www.nejm.org/doi/pdf/10.1056/NEJMoa2510308

Article linkㄩhttps://doi.org/10.1056/nejmoa2510308

Article SourceㄩMassachusetts Medical Society


Remarkㄩ

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
Georgee Post time The day before yesterday 15:17 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Return to the list